×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance
ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new...
2 days ago
Analysts Set Expectations for Esperion Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ESPR)
Defense World
Read Analysts Set Expectations for Esperion Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ESPR) at Defense World.
1 day ago
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Yahoo Finance
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript May 7, 2024 Esperion Therapeutics, Inc. beats earnings...
4 days ago
Esperion Shares Jump on Strong 1Q Results Above Analyst Expectations
MarketWatch
By Dean Seal Shares of Esperion Therapeutics climbed after the company's first-quarter results beat analyst forecasts. The stock was up 12%,...
5 days ago
Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today?
InvestorPlace
Esperion Therapeutics stock is up on Tuesday with heavy trading of ESPR shares after the company beat EPS and revenue estimates in Q1.
5 days ago
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
ANN ARBOR, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on May 8, 2024, the Company granted 16 new...
2 days ago
Esperion Therapeutics: Q1 Earnings Snapshot
Milford Mirror
ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported first-quarter net income of $61...
5 days ago
Earnings call: Esperion reveals robust Q1 growth, FDA approval boosts
Investing.com
Esperion Therapeutics Inc. (NASDAQ:ESPR) has reported a significant surge in its first-quarter revenue for 2024, with a total revenue of...
5 days ago
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
MSN
Esperion Therapeutics, Inc. ESPR reported earnings of 34 cents per share in the first quarter of 2024, against the Zacks Consensus Estimate of a loss of 8...
3 days ago
Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
AOL.com
Tuesday, Esperion Therapeutics (NASDAQ:ESPR) reported first-quarter revenues of $137.74 million, up 467% Y/Y, surpassing the consensus of $84.51 million.
4 days ago